biobeam 940 brochure - syrolight

2
   B    i    o    B    e    a    m     9    4    0 Bi o Beam TM 9 4 0 Phototherapy treatment Drug - free S ys t em Clinically tested Approved By The FDA Treatment for Pain and Rheumatological Diseases Canada Health Canada Santé Canada 0473

Upload: israel-exporter

Post on 09-Apr-2018

219 views

Category:

Documents


0 download

TRANSCRIPT

8/8/2019 BioBeam 940 Brochure - Syrolight

http://slidepdf.com/reader/full/biobeam-940-brochure-syrolight 1/2

   B   i   o   B   e

   a   m    9

   4   0

BioBeamTM

940

Phototherapy treatmentDrug- free SystemClinically tested

ApprovedBy The FDA

Treatment for

Pain andRheumatological Diseases

CanadaHealth

Canada

Santé

Canada0473

8/8/2019 BioBeam 940 Brochure - Syrolight

http://slidepdf.com/reader/full/biobeam-940-brochure-syrolight 2/2

Treatment of Pain and Rheumatological Diseases.A new, comprehensive phototherapeutic system for Treatment of Pain and RheumatologicalDiseases. TheBioBeamTM 94 0 Light Treatment System was found particularly effective

for the relief of pain in conditions such as: Osteoarthritis (degenerative joint disease) Chondromalacia patella (changes inthe cartilage of the kneecap) Chronic tendonitis (inflammation of the tendon) Chronic pain Treatment of Rheumatological Ailments

Joint inflammation, restricted movement, back pains and similar complaints have allbeen successful ly t reated wit h theBioBeamTM 94 0 system.

Proven Effectiveness in the Treatment of Rheumatological AilmentsClinical and experimental reports indicate that phototherapy has a positive effect on the treatment of pain and rheumatologicalailments. The BioBeamTM 940 Light Treatment System makes use of the demonstrated t herapeuti c properties of narrow bandlight, centered at the 940 nm wavelength region of the light spectrum.

BioBeamTM 94 0 – AdvantagesWhile traditional phototherapeutic methods are often prohibitively expensive and require a clinical setting, the lightweight,portable BioBeamTM 94 0 system is suitable for home use.

The BioBeamTM 940 Light Treatment System utilizes a dispersed beam, rather than the concentrated beam used by othersystems, making it safe enough for home use. Proven efficacy as an adjunct to conventional therapy Often effective in cases resistant to conventional therapy Simple and safe enough for home use Treatment is painless Self–contained No sensation of heat during treatment

BioBeamTM 94 0 – Modes of Operation Continuous Wave (CW) – for maximum total power Pulse – short pulses of high power f or maximum depth penetration.

Clinical resultsA study of the effectiveness of the BioBeamTM 940 light treatment system, presented at the Sixth International Conferenceon Optical Engineering in Tel Aviv, states in its conclusions:"…The BioBeamTM 94 0 system showed significant eff icacy in the t reatment of f acet joint osteoarthrit is, chronic tendonitis,

degenerative knee disease and chondromalacia of the patella.""…patients with degenerative knee disease and chondromalacia patella treated

with 940 nm low level narrow band light showed a significant improvementin pain, power, and ability to negotiate stairs and walking tolerance."

Additional BioLight products include:BioBeamTM  6 60 , BioBeamTM  ACNE, BioNaseTM, BioOralTM,BioProTM 162-660 and BioProTM 162-940.

L i    g 

h  t  T r  e  a  t   m e n  t  

 S  y  s  t   e  m

BioBeam™940

SYROSYROTECHNOLOGIES

R&D LTD

Technical Specifications

P.O.B. 8768, Jaffa 68117, Israel. Tel: +972-3- 6830981, Fax: +972-3- 5187149E - m a i l : s y r o f @ i s d n . n e t . i l , w w w . b i o l i g h t . c o . i l

Wavelength 940nmBeam area at focus 2 cm2

Continuous Wave (CW)Power at focus (typical) 25mw

Pulse WavePeak power at f ocus (t ypical) 75mwFrequency (typical) 150 HzDuty rat io (typical) 10%

Average power (typical) 7.5 mwPower RequirementsInput Voltage 120V-240VLine frequency 50-60Hz